AGIO vs ALLE · rev $65.5M vs P/E 21, rev $2.19B
Agios Pharm (AGIO) versus Allegion PLC (ALLE) — a side-by-side from cached financials, not a winner call.
Agios Pharm (AGIO) is a biotechnology company listed on US.
Allegion PLC (ALLE) is a security & protection services company listed on US.
Latest reported AGIO revenue for 2026-06-30 was $65.5M. Net income was -$199.8M. AGIO currently screens at market cap $1.68B.
Latest reported ALLE revenue for 2026-06-30 was $2.19B. Net income was $322.7M. ALLE currently screens at market cap $12.71B and trailing P/E 20.7.
AGIO currently screens at market cap $1.68B. ALLE currently screens at market cap $12.71B and trailing P/E 20.7.
Not investment advice. Open the AGIO and ALLE stock pages for the full models.
Not investment advice.